ZA892017B
Suppression of b-cells in mammals
Abstract
Selective suppression of B-lymphocytes in mammals is accomplished by treatment with an adequate amount of antibody to a mature B-lymphocyte surface marker.
Term
Term ended
Expired 16 March 2009, 17.5 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
16 members in 11 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 16926388 | United States of America | A |
Members16
| Document | Office | Kind | |
|---|---|---|---|
| NO891080D0 | Norway | D0 | |
| DK128789D0 | Denmark | D0 | |
| US4861579A | United States of America | A | |
| IL89334A0 | Israel | A0 | |
| IL89334D0 | Israel | D0 | |
| DK128789A | Denmark | A | |
| NO891080L | Norway | L | |
| EP0332865A2 | European Patent Office (EPO) | A2 | |
| AU3136689A | Australia | A | |
| KR890014130A | Republic of Korea | A | |
| JPH01275535A | Japan | A | |
| PT90011A | Portugal | A | |
| ZA892017BThis record | South Africa | B | |
| EP0332865A3 | European Patent Office (EPO) | A3 | |
| AU603326B2 | Australia | B2 | |
| PH26021A | Philippines | A |
Numbers
- Application
- 892017
Titles
- English
- SUPPRESSION OF B-CELLS IN MAMMALS
Classification
- CPC, 8
- C07K16/28
- A61K39/44
- A61K38/00
- A61K51/1027
- A61K2121/00
- A61K2123/00
- A61K47/6849
- A61P37/06
- IPC, 7
- A61K38 00
- A61K39 395
- A61K47 48
- A61K51 00
- A61K51 10
- A61P37 06
- C07K16 28